Found: 14
Select item for more details and to access through your institution.
Palbociclib (PD-0332991) pharmacokinetics in subjects with impaired renal function.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 6, p. 701, doi. 10.1007/s00280-020-04163-4
- By:
- Publication type:
- Article
Pharmacokinetics of alemtuzumab in pediatric patients undergoing ex vivo T-cell-depleted haploidentical hematopoietic cell transplantation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 6, p. 711, doi. 10.1007/s00280-020-04160-7
- By:
- Publication type:
- Article
Mass balance, metabolic disposition, and pharmacokinetics of [<sup>14</sup>C]ensartinib, a novel potent anaplastic lymphoma kinase (ALK) inhibitor, in healthy subjects following oral administration.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 6, p. 719, doi. 10.1007/s00280-020-04159-0
- By:
- Publication type:
- Article
The prognostic value of CA19-9 response after neoadjuvant therapy in patients with pancreatic cancer: a systematic review and pooled analysis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 6, p. 731, doi. 10.1007/s00280-020-04165-2
- By:
- Publication type:
- Article
Urine NGAL and KIM-1: tubular injury markers in acute lymphoblastic leukemia survivors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 6, p. 741, doi. 10.1007/s00280-020-04164-3
- By:
- Publication type:
- Article
Carboplatin re-treatment in platinum-resistant epithelial ovarian cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 6, p. 751, doi. 10.1007/s00280-020-04162-5
- By:
- Publication type:
- Article
Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 6, p. 761, doi. 10.1007/s00280-020-04168-z
- By:
- Publication type:
- Article
Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive glioma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 6, p. 773, doi. 10.1007/s00280-020-04169-y
- By:
- Publication type:
- Article
The biologically functional identification of a novel TIM3-binding peptide P26 in vitro and in vivo.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 6, p. 783, doi. 10.1007/s00280-020-04167-0
- By:
- Publication type:
- Article
Bioequivalence study of 20-mg and 100-mg temozolomide capsules (TOZ309 and Temodal<sup>®</sup>) in glioma patients in China.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 6, p. 793, doi. 10.1007/s00280-020-04175-0
- By:
- Publication type:
- Article
Association of lenvatinib plasma concentration with clinical efficacy and adverse events in patients with hepatocellular carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 6, p. 803, doi. 10.1007/s00280-020-04178-x
- By:
- Publication type:
- Article
Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 6, p. 815, doi. 10.1007/s00280-020-04176-z
- By:
- Publication type:
- Article
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212)
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 6, p. 829, doi. 10.1007/s00280-020-04171-4
- By:
- Publication type:
- Article
All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 6, p. 841, doi. 10.1007/s00280-020-04172-3
- By:
- Publication type:
- Article